1-methyl-3-isobutylxanthine and sermorelin

1-methyl-3-isobutylxanthine has been researched along with sermorelin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichinose, M; Maeno, T; Sawada, M1
Alfonso, A; Botana, LM; Estévez, MD; Louzao, MC; Vieytes, MR1

Other Studies

2 other study(ies) available for 1-methyl-3-isobutylxanthine and sermorelin

ArticleYear
Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages.
    Regulatory peptides, 1994, Dec-15, Volume: 54, Issue:2-3

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Dose-Response Relationship, Drug; Female; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Sermorelin; Vasoactive Intestinal Peptide

1994
Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cell Division; Cholera Toxin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; GTP-Binding Proteins; Histamine Release; Humans; Mast Cells; Peritoneum; Pertussis Toxin; Pleura; Rats; Rats, Sprague-Dawley; Sermorelin; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella

1995